Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
Determination of nitrite and nitrate in cerebrospinal fluid by microchip electrophoresis with microsolid phase extraction pre-treatment.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
Further validation of the Multiple Sclerosis Self-Efficacy Scale.
The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.
Emerging role of long noncoding RNAs in autoimmune diseases.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Central Nervous System Infections With Immunomodulatory Therapies.
[Cognitive Impairment in Multiple Sclerosis].
Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
Falls in people with MS-an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Isolation of bacterial plasmid-related replication-associated circular DNA from a serum sample of a multiple sclerosis patient.
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis.
NLRP3 Inflammasome and MS/EAE.

Pages